Grifols, S.A.
NASDAQ:GRFSDrug Manufacturers - General
+$0.03 today
- Market cap
- $7.17B
- Beta
- 1.17
- P/E (TTM)
- 14.7
- EPS (TTM)
- $0.61
- Dividend yield
- 1.67%
Volume 0.59M
Average 0.69M
GRFS Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Grifols, S.A.NASDAQ: GRFS
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization grows in line with its trailing trend
Q2 FY2026 depreciation & amortization of €107M rose 0.0% year over year, behind the +1.5% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 1.2% from the prior quarter. Over 3 fiscal years it compounded at +1.7% a year.
Context
- Depreciation & amortization amounted to 6.0% of revenue in FY2025, unchanged from a year earlier.
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from +0.0% toward the trailing-twelve-month pace of +1.5%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
EUR · from the income statement
- Latest · FY2025
- 432.24M EUR
- Year-over-year change
- -1.3%
- 4-year CAGR
- +4.7%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 432.24M | -1.3% |
| FY2024 | 2024-12-31 | 437.9M | -1.9% |
| FY2023 | 2023-12-31 | 446.42M | +8.6% |
| FY2022 | 2022-12-31 | 410.98M | +14.2% |
| FY2021 | 2021-12-31 | 359.77M | — |
Depreciation & Amortization vs competitors
How GRFS compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +1.5% is the highest of 9, against a peer median of -4.3%.
- Depreciation & amortization amounts to 6.0% of revenue for GRFS, versus a peer median of 8.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $2.54B USD | -19.0% | -1.6% | 5.3% | |
| LTM Sep 2026 | $2.24B USD | -4.2% | -0.7% | 11.1% | |
| LTM Mar 2026 | $447.8M USD | +0.5% | +15.9% | 16.9% | |
| LTM Jun 2026 | €443.93M EUR | +1.5% | +1.7% | 6.0% | |
| LTM Jun 2026 | $127.6M USD | -23.5% | +6.4% | 4.9% | |
| LTM Jun 2026 | $110.07M USD | -4.5% | +6.2% | 8.1% | |
| LTM Sep 2026 | $96.75M USD | -8.8% | -3.2% | 7.9% | |
| LTM Jun 2026 | $56.96M USD | -3.2% | +16.6% | 27.3% | |
| LTM Jun 2026 | $7.69M USD | -2.8% | +4.4% | 1.5% | |
| Peer median (excluding GRFS) | — | -4.3% | +5.3% | 8.0% | |
Competitors are the stored peer set for GRFS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 4.93B | 6.06B | 6.59B | 7.21B | 7.23B |
| Cost of Revenue | 2.97B | 3.85B | 4.11B | 4.42B | 4.65B |
| Gross Profit | 1.96B | 2.21B | 2.48B | 2.79B | 2.58B |
| Gross Margin | 39.8% | 36.5% | 37.7% | 38.7% | 35.7% |
| Research & Development | 354.88M | 361.14M | 395.28M | 384.04M | 358.28M |
| Selling, General & Admin | 1.06B | 1.11B | 1.27B | 1.14B | 1.02B |
| Operating Expenses | 1.37B | 1.43B | 1.7B | 1.6B | 1.39B |
| Depreciation & Amortization | 359.77M | 410.98M | 446.42M | 437.9M | 432.24M |
| EBITDA | 944.03M | 1.19B | 1.17B | 1.48B | 1.62B |
| EBITDA Margin | 19.1% | 19.7% | 17.7% | 20.6% | 22.5% |
| Operating Income | 595.06M | 782.44M | 782.32M | 1.19B | 1.19B |
| Operating Margin | 12.1% | 12.9% | 11.9% | 16.5% | 16.4% |
| Interest Income | 11.55M | 33.86M | 62.43M | 48.05M | 32.66M |
| Interest Expense | 233.81M | 444.54M | 516.06M | 773.16M | 600.33M |
| Other Income / Expenses | (244.61M) | (444.42M) | (575.3M) | (748.02M) | (596.49M) |
| Income Before Tax | 350.45M | 338.01M | 207.02M | 444M | 590.73M |
| Pre-Tax Margin | 7.1% | 5.6% | 3.1% | 6.2% | 8.2% |
| Income Tax Expense | 85.13M | 90.11M | 43.35M | 231.19M | 110.46M |
| Net Income | 188.73M | 185.04M | 42.32M | 156.92M | 386.13M |
| Net Margin | 3.8% | 3.1% | 0.6% | 2.2% | 5.3% |
| EPS (Basic) | 0.27 | 0.31 | 0.09 | 0.23 | 0.57 |
| EPS (Diluted) | 0.27 | 0.31 | 0.09 | 0.23 | 0.57 |
| Weighted Avg Shares | 681.56M | 679.81M | 679.76M | 680.02M | 680.58M |
| Weighted Avg Shares (Diluted) | 681.56M | 679.81M | 679.76M | 680.02M | 680.58M |
Grifols, S.A.
NASDAQ:GRFS
Intrinsic Alpha fair value
Locked
Current Price
$8.47
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.